Patient assessments of the risks and benefits of arthritis treatments differ by race, according to a report in the April 15th issue of Arthritis & Rheumatism. Reuters Health Information
High-dose recombinant erythropoietin is well tolerated and can be safely given to very preterm infants, according to the results of two studies in the August issue of Pediatrics. Reuters Health Information
The European Medicines Agency says that it has started a review of orlistat-containing medicines to determine whether the "very rare cases of hepatic injury have an impact on their benefit/risk profile and conditions of use." Heartwire
The first evidence-based guidelines urge reducing the dose of colchicine in patients also taking some common cardiovascular drugs and antibiotics. Medscape Medical News
Dr. Lidia Schapira looks at the striking results of the CLEOPATRA trial, which combined 2 anti-HER2-positive drugs, pertuzumab and trastuzumab, as first-line therapy in metastatic breast cancer. Medscape Hematology-Oncology
